Clinical assessment tool evaluating arterial health and identifying patients at elevated risk for cardiovascular, metabolic, renal, and neurological diseases. Generates objective vascular biomarker data to guide clinical decision-making and patient management.
Manufactured by
China
Cardiex is a digital health technology company developing and marketing noninvasive patient monitoring technologies for cardiovascular health assessment. The company's FDA-cleared and patented SphygmoCor vascular biosensing technology is deployed in over 4,500 installations worldwide at major medical and research institutions for clinical diagnosis and management of hypertension and cardiovascular diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
Chengdu Stork Healthcare Co.,Ltd.
China · 1 relevant product
Wuhan Jiule Technology Co., Ltd
China · 1 relevant product
KARDI AI Technologies s.r.o
Czech Republic · 1 relevant product
Shandong Kanghua Biotechnology Co.,Ltd.
China · 2 relevant products
Siemens Healthineers
United States · 3 relevant products
Viasonix Ltd.
Israel · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
TALOS Corp.
South Korea · 1 relevant product
KANROTA
China · 1 relevant product
20 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 41 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cardiovascular disease screening and risk stratification. Incorporates genetic and molecular markers for personalized cardiovascular health management.
Chengdu Stork Healthcare Co.,Ltd. · China
Automated system for real-time cardiovascular metric measurement and assessment, including carotid plaque detection and evaluation. Significantly improves diagnostic efficiency and accuracy in cardiovascular risk stratification.
Wuhan Jiule Technology Co., Ltd · China
Risk stratification system for chronic disease identification through continuous health parameter monitoring. Leverages AI algorithms and wearable sensor data for predictive health risk evaluation.
KARDI AI Technologies s.r.o · Czech Republic
Analytical software for measuring and interpreting heart rate variability from cardiac monitoring recordings. Provides quantitative assessment of autonomic nervous system function through spectral and time-domain analysis. Used for risk stratification and functional assessment.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Diagnostic tests for cardiovascular biomarkers including troponin, BNP, and lipid profiles. Enables rapid assessment of cardiac function and risk stratification in clinical settings.
Siemens Healthineers · United States
Integrated platform for advanced biomarker analysis supporting early disease detection, risk stratification, and prognostic assessment across cardiometabolic, liver, cardiovascular, and brain health conditions.
Viasonix Ltd. · Israel
Integrated assessment protocol combining transcranial Doppler findings with clinical data for cerebrovascular risk evaluation. Identifies high-risk patients requiring intervention.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Test kits for measurement of cardiac biomarkers indicating myocardial infarction and heart disease. Essential for acute cardiac event diagnosis and risk stratification.
Anbio Biotechnology Limited · Germany
Comprehensive assay panel for detection of cardiac-related biomarkers including troponin and natriuretic peptides. Supports diagnosis and risk stratification of cardiovascular diseases.
TALOS Corp. · South Korea
An artificial intelligence algorithm that evaluates clinical data to predict brain aneurysm risk levels in patients. The system provides quantitative risk stratification to support clinical decision-making for preventive interventions. Applicable to screening programs across healthcare organizations.
Siemens Healthineers · United States
Integrated testing platform providing comprehensive evaluation of cardiometabolic health parameters for earlier risk detection. Supports longitudinal monitoring and holistic patient assessment.
KANROTA · China
Integrated assessment system for identifying osteoporosis risk and fracture probability. Combines bone density measurement with clinical risk factor analysis. Supports primary and secondary prevention screening.
29 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products